Chlorosuccinimide → 4-Chlorosampangine

HRID 483837노트

반응식

HRID 483837 반응식
[Cl:1]N1C(=O)CCC1=O.[CH:9]1[CH:10]=[CH:11][C:12]2[C:25](=[O:26])[C:24]3[C:16]4[C:17]([CH:21]=[CH:22][N:23]=3)=[CH:18][CH:19]=[N:20][C:15]=4[C:13]=2[CH:14]=1>CN(C=O)C>[CH:9]1[CH:14]=[C:13]2[C:15]3[C:16]4[C:24]([C:25](=[O:26])[C:12]2=[CH:11][CH:10]=1)=[N:23][CH:22]=[C:21]([Cl:1])[C:17]=4[CH:18]=[CH:19][N:20]=3

참가 물질

4

반응물 2

HCID 31398ChlorosuccinimideHCID 3871957H-Naphtho(1,2,3-ij)(2,7)naphthyridin-7-one

생성물 1

HCID 100385854-Chlorosampangine수율 53.2%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

반응 조건

온도
100 °C

실험 절차

N-Chlorosuccinimide (200 mg, 1.5 mmol) was added to a suspension of sampan-gine (232 mg, 1.0 mmol) in DMF (10 mL) and the mixture stirred at 100° C. for 24 h. The reaction was then poured onto H2O (100 mL) and the solids isolated by filtration. The crude product was purified by column chromatography eluting with CHCl3 /EtOAc (9:1) to give 4-chlorosampangine (21) (142 mg, 53%). Crystallization from EtOAc provided an analytical sample: mp 262°-263° C.; IR (KBr) 1670, 1590, 1410, 1315, 1278, 1240, 1230, 1000, 790, 758, 725, 610 cm-1 ; 1H NMR (CDCl3) δ 7.68 (ddd, 1H, J=7.6, 7.6, 1.4 Hz), 7.81 (ddd, 1H, J=7.6, 7.6, 1.4 Hz), 7.95 (d, 1H, J=5.9 Hz), 8.41 (dd, 1H, J=7.6, 1.4 Hz), 8.76 (dd, 1H, J=7.6, 1.4 Hz), 8.93 (d, 1H, J=5.9 Hz), 9.09 (s, 1H); 13C NMR (CDCl3) 115.7 (1), 120.0 (0), 125.6 (1), 128.5 (1), 131.7 (1), 132.0 (0), 132.2 (0), 134.8 (1), 135.0 (0), 136.9 (0), 146.0 (0), 147.2 (1), 148.2 (1), 151.5 (0), 181.2 (0) ppm; Anal. calcd for C15H7ClN2O: C 67.56, H 2.65, N 10.50; found C 67.63, H 2.52, N 10.54.

후처리

  1. additionThe reaction was then poured onto H2O (100 mL)
  2. customthe solids isolated by filtration
  3. customThe crude product was purified by column chromatography
  4. washeluting with CHCl3 /EtOAc (9:1)

출처 및 근거

ORD 기록
ord-f32a4b275fb44f8480257c09ff17f4d0
출처 데이터셋
uspto-grants-1993_07
특허 번호
US05227383

반응 노트

불러오는 중…